Crossmark

Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease

Crossref DOI link: https://doi.org/10.1016/j.gastre.2022.05.003

Published Print: 2023-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Amiama Roig, Clara

Suárez Ferrer, Cristina

Rueda García, Jose Luis

Poza Cordón, Joaquín

Sánchez-Azofra, María

Martín Arranz, Eduardo

González Díaz, Irene

Amor Costa, Carmen

Martín-Arranz, María Dolores
License Information

Text and Data Mining valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01

stm-asf valid from 2023-02-01
More Information

This article is maintained by: Elsevier

Article Title: Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2022.05.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.gastrohep.2022.05.010

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. All rights reserved.